Volver al buscador
FDAFDA · Alimentos y medicamentos·N.º oficial Z-2167-2018

The VITEK® 2 Gram Positive Susceptibility Card is intended for use with the VITEK 2 Systems in clinical laboratories as an in vitro test to determine the susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae to antimicrobial agents. Fully automated short-term incubation cycle antimicrobial susceptibility system is a device that incorporates concentrations of antimicrobial agents into a system for the purpose of determining in vitro susceptibility of bacterial pathogens isolated from clinical specimens. Test results obtained from short-term (less than 16 hours) incubation are used to determine the antimicrobial agent of choice to treat bacterial diseases.

Publicado el 20 de junio de 2018 · Inicio del retiro: 23 de marzo de 2018

Resumen

FDA registra el retiro Z-2167-2018 de dispositivos médicos de Clase II, publicado el 20 de junio de 2018 e iniciado el 23 de marzo de 2018. Empresa responsable: BioMerieux SA; Estado: Finalizado; Cantidad reportada: 5 boxes with AST-P606 TEST KIT 20 CARDS; Lote: VITEK® 2 AST-P606 (ref: 22330): Lot Number 4860117403. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.

Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.

Qué peligro representa

A shipment to Guadeloupe suffered a temperature excursions up to 47.8®C, exceeding the acceptable limits. After detection of the issue, Global Supply Chain QA asked the bioM®rieux distributor in Guadeloupe to put products in quarantine in July 2017; After several reminders, the distributor informed in November 2017 that products were delivered to customers.

Qué hacer

Voluntary: Firm initiated · Letter

Recibe un correo cuando FDA publique un retiro como este

Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.

Detalles del retiro

Fabricante
BioMerieux SA
Distribuidor
International distribution.
Lote
VITEK® 2 AST-P606 (ref: 22330): Lot Number 4860117403
Clasificación de riesgo
Class II
Área (FDA)
device
País
France

Retiros relacionados

Preguntas sobre este retiro

¿The VITEK® 2 Gram Positive Susceptibility Card is intended for use with the VITEK 2 Systems in clinical laboratories as an in vitro test to determine the susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae to antimicrobial agents. Fully automated short-term incubation cycle antimicrobial susceptibility system is a device that incorporates concentrations of antimicrobial agents into a system for the purpose of determining in vitro susceptibility of bacterial pathogens isolated from clinical specimens. Test results obtained from short-term (less than 16 hours) incubation are used to determine the antimicrobial agent of choice to treat bacterial diseases. fue retirado del mercado?

Sí. FDA publicó el retiro Z-2167-2018 el 20 de junio de 2018. Peligro reportado: A shipment to Guadeloupe suffered a temperature excursions up to 47.8®C, exceeding the acceptable limits. After detection of the issue, Global Supply Chain QA asked the bioM®rieux distributor in Guadeloupe to put products in quarantine in July 2017; After several reminders, the distributor informed in November 2017 that products were delivered to customers.

¿Qué debo hacer si tengo este producto?

Voluntary: Firm initiated · Letter